Dr Reddys Laboratories annual r&d spending
2018
2019
2020
2021
2022
2023
2024
2025
Dr Reddys Laboratories R&D Spending Growth & History (RDY)
Dr Reddys Laboratories's r&d spending was $320.0M for fiscal 2025.
View full Dr Reddys Laboratories company overviewDr Reddys Laboratories annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-03-31 | $320.0M | $46.0M | +16.79% |
| 2024 | 2024-03-31 | $274.0M | $38.0M | +16.10% |
| 2023 | 2023-03-31 | $236.0M | $6.0M | +2.61% |
| 2022 | 2022-03-31 | $230.0M | $4.0M | +1.77% |
| 2021 | 2021-03-31 | $226.0M | $22.0M | +10.78% |
| 2020 | 2020-03-31 | $204.0M | −$22.0M | −9.73% |
| 2019 | 2019-03-31 | $226.0M | −$55.0M | −19.57% |
| 2018 | 2018-03-31 | $281.0M | — | — |
Dr Reddys Laboratories r&d spending trends
Over the last five fiscal years, Dr Reddys Laboratories's r&d spending increased from $204.0M to $320.0M, a change of $116.0M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dr Reddys Laboratories source filings ↗